SHERI ROLEWSKI: Open Payments
NPI 1912033994 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$365 in 18 payments from 9 companies in 2025. Trend: 2023 $1,794 · 2024 $1,023 · 2025 $365
Food & beverage: $265Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $149 |
| Janssen Biotech, Inc. | 1 | $100 |
| UCB, Inc. | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Incyte Corporation | 1 | $19 |
| Arcutis Biotherapeutics, Inc. | 1 | $19 |
| GENZYME CORPORATION | 1 | $17 |
| LEO Pharma Inc. | 1 | $14 |
| Organon LLC | 1 | $5 |
Products named: SKYRIZI, TREMFYA, Bimzelx, COSENTYX, OPZELURA, Zoryve, DUPIXENT, ADBRY.
Industry payments across PA — which companies pay providers there.
